Free Trial

OS Therapies (OSTX) Insider Trading & Ownership

OS Therapies logo
$2.95 -1.17 (-28.40%)
As of 01/17/2025 04:00 PM Eastern

OS Therapies (NYSE:OSTX) Insider Buying and Selling Activity

Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$112,692.80
Get OSTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling OS Therapies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

OSTX Insider Buying and Selling by Quarter

OS Therapies Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/15/2025Shalom AuerbachMajor ShareholderSell16,720$6.74$112,692.80  
(Data available from 1/1/2013 forward)

OSTX Insider Trading Activity - Frequently Asked Questions

The list of insiders at OS Therapies includes Shalom Auerbach. Learn more on insiders at OSTX.

The following insider sold OSTX shares in the last 24 months: Shalom Auerbach ($112,692.80).

Insiders have sold a total of 16,720 OS Therapies shares in the last 24 months for a total of $112,692.80 sold.

OS Therapies Key Executives

  • Mr. Paul A. Romness M.P.H. (Age 58)
    Founder, President, CEO & Director
    Compensation: $360k
  • Dr. Robert G. Petit Ph.D. (Age 64)
    Chief Medical Officer & Chief Scientific Officer
    Compensation: $300k
  • Mr. Christopher P. Acevedo (Age 61)
    Chief Financial Officer
  • Mr. Jack Doll
    Chief of Staff
  • Mr. Gerald E. Commissiong (Age 42)
    Chief Business Officer


This page (NYSE:OSTX) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners